Arca
Skip to content
Tools
Tools

SleepCheckRx

Ventilatory Effort Recorder. 510(k) K213360, from Resapp Health (Brisbane, AU). Product code MNR, class 2.

As of Nov 18, 2026, K213360 is an FDA 510(k) held by Resapp Health, substantially equivalent on Jul 5, 2022 after 266 days, with no recalls tied to it in FDA's recall database.

  • Review time: 266 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

SleepCheckRx is indicated to record a patient's respiratory pattern during sleep for the purpose of pre-screening patients for obstructive sleep apnea (OSA) syndrome. The device is designed for use in home-screening of adults (≥ 22 years of age) with suspected possible sleep breathing disorders.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF
  • DrowzleK173974 · Resonea, Inc. · Jul 14, 2019

Other MNR clearances

The newest 510(k)s for the same product code; their median review was 219 days; see every MNR device

Record

Type
Traditional
Received
Oct 12, 2021
Review panel
Anesthesiology
Regulation
21 CFR 868.2375

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.